Head over to our on-demand library to view sessions from VB Transform 2023. Register Here Collaborative presentation platform Pitch today announced it has raised $85 million in a series B round of ...

Predictors of functional recovery after thrombectomy in posterior circulation stroke: Insights from the STAR collaboration. Alawieh AM, Eid M, Anadani M, Sattur M, Chalhoub R, Maier I, et al.

Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025 Principal Investigator Alireza Faridar, M.D. to provide overview of data for the ...

Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled “Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability,” alongside ...

The What: Atlona is unveiling the AT-WAVE-101 wireless presentation and collaboration platform. Designed for easy content sharing from iOS, Android, Mac, Chromebook and Windows devices, the WAVE-101 ...

Introduction In professional work, presentations are not just slides. They are decisions in progress. A founder uses a deck to convince investors. A sales Learn what an AI presentation maker is, how ...

With its combination of AI-driven slideshow generation, intuitive PPT editing, and a vast library of templates, AiPPT positions itself as a one-stop solution for modern presentation needs. Whether ...

The Drexel University College of Medicine’s annual research day, called Discovery Day, will this year boast over 300 presentations on biomedical science and clinical research topics from doctoral, ...

BEDFORD, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today multiple presentations on HMI-203 gene therapy candidate for the ...

PowerPoint may still dominate the landscape for presentations in many people’s minds, but some might say that legacy status also makes Microsoft’s software ripe for disruption. Now, a startup out of ...

Principal Investigator Alireza Faridar, M.D. to provide overview of data for the investigator-initiated “Phase II Clinical Trial of Interleukin-2 (IL-2) in Patients with Mild to Moderate Alzheimer’s ...